Premium
Bacterial infections following non‐ablative fractional laser treatment: A case series and discussion
Author(s) -
Xu Lisa Y.,
Kilmer Suzanne L.,
Ross E. Victor,
Avram Mathew M.
Publication year - 2015
Publication title -
lasers in surgery and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 112
eISSN - 1096-9101
pISSN - 0196-8092
DOI - 10.1002/lsm.22315
Subject(s) - ablative case , medicine , sepsis , laser therapy , laser , dermatology , surgery , radiation therapy , optics , physics
Non‐ablative fractional laser procedures have become increasingly popular since their introduction in 2004. The fractional 1,927 nm thulium laser is a non‐ablative device that penetrates up to 300 μm in the skin and the 1,550 nm erbium:glass laser penetrates up to 1,400 μm. These procedures are considered minimally invasive with a high safety profile; therefore, infectious complications are exceedingly rare. However, we report five recent cases of bacterial infection with both gram‐positive and gram‐negative organisms following treatment with the fractional 1550/1927 nm laser approximately 1 day to 1 week post‐procedure. One patient had a rapidly progressing pustular eruption with symptoms of sepsis. These patients were seen immediately, cultures were obtained and empiric antibiotic therapy was initiated. They recovered without long‐term complications. Rapid‐onset bacterial infections following non‐ablative laser resurfacing with the 1550/1927 nm laser have not been previously reported in the literature. The infections can progress quickly and lead to serious sequelae, including systemic illness and severe scarring, if not identified and appropriately treated. We present these cases to highlight the importance of close surveillance and when appropriate, rapid intervention, following non‐ablative fractional procedures, especially when patients present with atypical symptoms and signs. Lasers Surg. Med. 47:128–132, 2015. © 2015 Wiley Periodicals, Inc.